Find your PDFs fast.
Welcome to the Pubget Medical Subject Headings (MESH) browser. Click on a topic or subtopic below to explore related papers. In the gold box is the most recent paper about the current MESH term, and below are 20 related papers.
Receptor, Serotonin, 5-HT2C (0):
Recent article
Receptor, Serotonin, 5-HT2C
Abstract
We recently found that the response of DBA/2 mice to SSRIs in the forced swim test (FST) was impaired and they also had a smaller basal and citalopram-stimulated increase in brain extracellular serotonin (5-HT) than 'responder' strains. We employed intracerebral microdialysis, FST and selective anta...
|
PMID: 19123962
PDF is available here.
PDF is available here.
| < More recent | Older article > |
Abstract
Bodyweight gain is a common side effect of treatment with antidepressive drugs; however, little is known about the mechanisms behind this weight gain. Genetic differences may contribute to the susceptibility for bodyweight gain during antidepressive treatment. The objective of this study was to exam...
|
PMID: 19474754
PDF is available here.
PDF is available here.
Abstract
Pharmacophore modelling, docking and virtual screening have become important tool in drug discovery process. Serotonin 2C (5-HT(2C)) receptor ligands have got major attention for their therapeutic uses as antidepressant and anorectic agents. Two step pharmacophore and docking based v...
|
PMID: 19464901
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.
Neuropharmacology (57)1 2009
Abstract
We show in the present study that the purported selective 5-HT(2C) receptor antagonist, SB242,084, dose-dependently counteracts citalopram-induced inhibition of serotonin cell firing. Even though the effect of SB242,084 is significant at a dose found in vivo to also partially occupy 5-HT(2A) recepto...
|
PMID: 19376075
PDF is available here.
PDF is available here.